Standard workplace drug panels and athletic anti-doping screens look for very different things. This guide explains which peptides are detectable, on what tests, for how long, and why a 'purity CoA' is unrelated to forensic detection.
The short answer
No: standard 5-panel and 10-panel workplace drug tests (amphetamines, cocaine, opiates, PCP, THC, benzodiazepines, barbiturates, methadone, MDMA, propoxyphene) do not screen for peptides. Peptides are large molecules that require specialised LC-MS/MS assays to detect, and routine workplace labs simply don't run those assays.
Yes: sport anti-doping screening (WADA, ASADA, USADA, NRL, AFL, UFC, NCAA) does test for many peptides, and detection windows can extend from hours to several weeks depending on the molecule.
Why workplace tests miss peptides
Workplace drug screens are immunoassays (cheap antibody-based tests) optimised for small-molecule recreational drugs. Peptides like BPC-157, TB-500, ipamorelin, CJC-1295, and tirzepatide are too large and too structurally specific to cross-react with those antibodies. Even if you walked into a workplace medical with measurable peptide in your blood, the test would return negative for every panel.
The exception is medications that contain peptides triggering a positive on related panels (e.g. some pain medications metabolising to codeine-positive results). Pure research peptides do not.
What sport anti-doping actually tests for
WADA's Prohibited List includes entire classes of peptides as S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). The big categories:
Growth hormone secretagogues: ipamorelin, CJC-1295, GHRP-2, GHRP-6, hexarelin, MK-677, sermorelin, tesamorelin. All prohibited at all times.
Growth hormone releasing peptides + GHRH analogues: same class, same prohibition.
GLP-1 / GIP agonists: semaglutide, tirzepatide, retatrutide, liraglutide. Not on the current WADA list as performance enhancers, but body-composition manipulation can attract scrutiny in weight-class sports.
Recovery / repair peptides: BPC-157 is on the WADA Prohibited List (S0, non-approved substances) at all times.
TB-500 (thymosin beta-4): prohibited at all times under S2.
Selective androgen receptor modulators (SARMs): not peptides, but commonly bundled. Prohibited under S1.
Detection windows: what to expect
Detection time depends on the peptide's plasma half-life, dose, frequency of use, and the lab's limit of detection. Rough orders of magnitude from published anti-doping research:
Ipamorelin / GHRP-2 / GHRP-6: typically detectable in urine for 24-72 hours after a single dose.
CJC-1295 with DAC: extended half-life (5-8 days); detectable for 1-2 weeks.
BPC-157: short plasma half-life but tissue distribution means tested windows of 1-7 days post-dose are commonly cited.
TB-500: detectable for up to several weeks after injection.
GH itself: detected via the GH isoform test (window ~24 hours) and the GH biomarker test (window up to 14+ days).
These are indicative ranges, not legal advice. Actual outcomes depend on the testing body's methodology and your personal pharmacokinetics.
Where purity testing fits in (and where it doesn't)
A LabDoc Certificate of Analysis tells you what is in the vial: identity (LC-MS), purity (HPLC), and peptide content. It does not tell you whether the peptide will be detected on an anti-doping screen, because forensic detection is about you, the dose, and time, not the vial. Purity testing is about avoiding contaminants and confirming you're getting the molecule you paid for. The two questions ('is this real peptide?' and 'will I test positive?') are completely separate.
Practical implications for Australian users
Standard workplace drug tests: peptides will not show up, regardless of source. Confirm with your employer's medical provider if you have any uncertainty about the panel used.
Tested athlete (any WADA-affiliated body, including most Australian professional and elite amateur sport): assume any GH-axis peptide, BPC-157, TB-500, or related compound is detectable for at least one week, often longer. A therapeutic use exemption (TUE) is the only legal path.
Police roadside / saliva tests: screen for THC, methamphetamine, MDMA, cocaine. Peptides do not register.
Ask the testing provider for the panel name and exact assay list. If it's a 5-panel or 10-panel SAMHSA-style screen, peptides aren't on it. If it's a WADA in-competition or out-of-competition test, the S2 hormone panel is run via LC-MS/MS and most peptides on the prohibited list are detectable.
Frequently asked questions
Will BPC-157 show up on a workplace drug test?
No. Standard 5-panel and 10-panel workplace drug screens do not test for BPC-157 or any other research peptide. They are immunoassays designed for small-molecule recreational drugs.
Does tirzepatide or semaglutide show on drug tests?
Not on workplace tests. They are not on the WADA Prohibited List as performance enhancers either, though body-composition effects can attract scrutiny in weight-class sports.
How long are peptides detectable in WADA testing?
It depends on the peptide. Short-acting growth hormone secretagogues like ipamorelin are detectable for 1-3 days; long-acting forms like CJC-1295 with DAC for 1-2 weeks; TB-500 has been reported detectable for several weeks.
Does a clean Certificate of Analysis mean I won't test positive?
No. A CoA confirms what's in the vial, not whether the peptide will be detected in your system. Identity and purity testing and forensic anti-doping testing are unrelated processes.
Can a TUE cover peptide use for sport?
A Therapeutic Use Exemption can permit medically necessary use of some prohibited substances, but most peptides in this category are not approved for the indications athletes commonly cite, so TUE approval is rare. Check with your sport's anti-doping authority.